The new centre has been envisioned to cater to the company's growing global portfolio of clients in the automotive, aerospace and construction/heavy engineering verticals
Tata Technologies announced the opening of its new global engineering centre in Bangalore.
The new centre has been envisioned to cater to the company's growing global portfolio of clients in the automotive, aerospace and construction/heavy engineering verticals, engaging high-end engineering talent available here, the company said in a statement.
"While we have been active here for the last few years, we want to significantly ramp-up in Bangalore, keeping in mind the large pool of qualified engineering and IT professionals who prefer living and working in Bangalore", Tata Technologies President (Global Delivery) Gopinath Jayaraj said.
Natco has filed an ANDA seeking USFDA approval for marketing these tablets in the strength of 250 mg
Drug firms Lupin Ltd and Natco Pharma today said that they have entered into an alliance to jointly market generic Lapatinib Ditosylate tablets, used for treating breast cancer, in the American market.
Natco has filed an abbreviated new drug application (ANDA) seeking United States Food and Drug Administration (USFDA) approval for marketing these tablets in the strength of 250 mg, Natco and Lupin Ltd said in separate statements.
"Natco has partnered with Lupin for marketing of the product," Natco Pharma said in a filing to the Bombay Stock Exchange (BSE).
Lapatinib Ditosylate tablets are sold under the brand name Tykerb in the American market. The patent of Tykerb is with Glaxo.
"Tykerb had sales of $113.6 million as of March 2011, according to IMS health," Lupin said.
"Natco and Lupin believe that they are the first to file an ANDA containing a paragraph IV certification for Lapatinib," it added.
This means that once their ANDA is approved, the firms could have 180 days' exclusivity for the product in the US.
On Thursday, Lupin ended 1.2% up at Rs430.15 on the Bombay Stock Exchange, while the benchmark Sensex gained 1.01% to 17,727.49.
The benefit of the bill payment facility is that payments are instantaneous and can be made anytime and anywhere
Mahanagar Telephone Nigam (MTNL) said it has tied up with Atom Technologies, a leading provider of m-Commerce solutions, for enabling its customers to make bill payments through mobile or landline phones.
MTNL provides telecom services to over 17 lakh customers across Mumbai. This service offers the convenience to a vast number of customers to make their bill payments instantly through phones using their credit cards.
The benefit of this facility is that payments are instantaneous and can be made anytime and anywhere—from home, office or while travelling—through any of the MTNL phones, the company said in a statement.
The atom platform provides a secure and automated environment to end customers with complete assurance of protection of their credit card details. Atom is the largest m-Commerce solutions provider in the country with over 80% market share for its IVR solution.
Till date, atom has processed more than Rs2,000 crore worth of transactions on its platform. Its clientele comprise of 400 plus best associates throughout the industry and include corporates, government utilities, travel and tourism firms, insurance companies etc.
On Thursday, MTNL ended 2.14% down at Rs14.15 on the Bombay Stock Exchange, while the benchmark Sensex gained 1.01% to 17,727.49.